Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients

• Punt CJA,
• Figdor C F,
• Adema G J,
• Van Rossum M,
• Lesterhuis W J,
• Aarntzen EHJG,
• De Vries IJM

Affiliations

Punt CJA

Figdor C F

Adema G J

Van Rossum M

Lesterhuis W J

Aarntzen EHJG

De Vries IJM